Clin2
NCT07708181Possibly a fitNot yet recruiting

Study of a new medicine to prevent gout flares

Gout Arthritis

Treatments studied

Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.

This study tests a medicine called SSGJ-613 to see if it can reduce gout flares when people start treatment to lower uric acid. It may help people who have frequent gout attacks.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
200 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • Your body mass index (BMI) is 40 or less.
  • You have been diagnosed with gout.
  • You have had at least 4 gout flares in the past year.
  • You do not have severe kidney problems or active infections.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07346079Recruiting· Phase 4
Corticotropin gel for acute gout flares

This study tests two doses of a medicine called Purified Cortrophin Gel for people having a gout flare that started in the last 5 days. It might be an option if other treatments haven't worked or aren't safe for you.

Boston, Massachusetts
NCT07369622Not yet recruiting· Phase 4
Gene-guided gout treatment for safer, effective care

This study tests whether a genetic test can help doctors choose the safest and most effective gout medication. It aims to prevent severe allergic reactions by personalizing treatment based on your genes.

NCT07842497Not yet recruiting· Phase 2
New treatment for sudden gout attacks

This study tests a new medication for people with sudden gout flare-ups who haven't gotten relief from or can't take the usual treatments. It may help reduce pain and inflammation faster, and you'll receive either the study drug or a placebo (inactive treatment) along with standard care.

Jing’an, Shanghai Municipality
NCT07145229Recruiting· Phase 2
Testing a new drug for acute gout flares

This trial tests a new medication, ABP-745, for people having an acute gout flare. It aims to see if the drug is safe and helps reduce pain and inflammation.

Peoria, Arizona
NCT07587684Recruiting· Phase 1
Testing IN026 for Hard-to-Treat Gout

This study tests a new drug called IN026 for people with refractory gout—gout that doesn't respond well to current treatments and causes severe symptoms. The goal is to see if IN026 can lower uric acid levels and reduce gout attacks.

Wuhan
NCT07706777Recruiting· Phase 2
Testing a new drug for acute gout flares

This trial tests an oral medication (HRS-2129) to see if it can calm a sudden gout flare and reduce joint pain. It may help if you are currently having a moderate-to-severe gout attack and are otherwise in good health.

Guangzhou, Guangdong

Hear when a new Gout Arthritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.